TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC) Meeting Abstract


Authors: Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; Gonzalez, J.; Giri, D. D.; Patil, S.; Feigin, K.; D'Andrea, G.; Theodoulou, M.; Drullinsky, P.; Sklarin, N. T.; Hudis, C.; Traina, T. A.; Translational Breast Cancer Research Consortium
Abstract Title: TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880304547
DOI: 10.1200/jco.2011.29.15_suppl.tps122
PROVIDER: wos
Notes: Meeting Abstract: TPS122 -- Source: Wos
Altmetric Score